Literature DB >> 17431209

Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study.

Daniel G Hackam1, J David Spence.   

Abstract

BACKGROUND AND
PURPOSE: Numerous effective strategies for the secondary prevention of cardiovascular events in high-risk patients have now been established. We sought to calculate the cumulative benefit of combining multiple strategies for preventing recurrent events in patients with a history of ischemic stroke or transient ischemic attack.
METHODS: A comprehensive literature search was undertaken to identify meta-analyses of randomized controlled trials reporting on the efficacy of secondary prevention strategies. The baseline incidence of vascular events was modeled from the Life Long After Cerebral Ischemia study. Strategies were combined on a multiplicative scale and cumulative risk reductions were computed over a 5-year interval.
RESULTS: The combination of 5 proven strategies applied to survivors of an initial stroke or transient ischemic attack--dietary modification, exercise, aspirin, a statin, and an antihypertensive agent--could result in a cumulative relative risk reduction of 80%. Given a 5-year major cardiovascular event rate of 24%, this translates to a number needed to treat of about 5. Further gains would result from applying multimodality therapy over longer intervals and enriching the base strategy with dual antiplatelet therapy, high-dose statins, and more intensive blood pressure-lowering. Even more benefit would be present in high-risk subgroups with the addition, where appropriate, of carotid endarterectomy, moderate intensity oral anticoagulants, glycemic control, and smoking cessation.
CONCLUSIONS: At least four-fifths of recurrent vascular events in patients with cerebrovascular disease might be prevented by application of a comprehensive, multifactorial approach.

Entities:  

Mesh:

Year:  2007        PMID: 17431209     DOI: 10.1161/STROKEAHA.106.475525

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  77 in total

1.  Balancing evidence and opinion in stroke care: the 2008 best practice recommendations.

Authors:  Mark Bayley; Patrice Lindsay; Chelsea Hellings; Elizabeth Woodbury; Stephen Phillips
Journal:  CMAJ       Date:  2008-12-02       Impact factor: 8.262

Review 2.  Management of Patients with an Asymptomatic Carotid Stenosis--Medical Management, Endovascular Treatment, or Carotid Endarterectomy?

Authors:  J David Spence
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

3.  Nontraditional serum lipid variables and recurrent stroke risk.

Authors:  Jong-Ho Park; Juneyoung Lee; Bruce Ovbiagele
Journal:  Stroke       Date:  2014-09-18       Impact factor: 7.914

Review 4.  Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design.

Authors:  Keun-Sik Hong; Sharon Yegiaian; Meng Lee; Juneyoung Lee; Jeffrey L Saver
Journal:  Circulation       Date:  2011-05-02       Impact factor: 29.690

5.  Combined Aerobic Exercise and Task Practice Improve Health-Related Quality of Life Poststroke: A Preliminary Analysis.

Authors:  Anson B Rosenfeldt; Susan M Linder; Sara Davidson; Cynthia Clark; Nicole M Zimmerman; John J Lee; Jay L Alberts
Journal:  Arch Phys Med Rehabil       Date:  2018-12-10       Impact factor: 3.966

Review 6.  Stroke, Vascular Dementia, and Alzheimer's Disease: Molecular Links.

Authors:  Murali Vijayan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2016-09-06       Impact factor: 4.472

7.  The preventing recurrent vascular events and neurological worsening through intensive organized case-management (PREVENTION) trial protocol [clinicaltrials.gov identifier: NCT00931788].

Authors:  Finlay A McAlister; Sumit R Majumdar; Rajdeep S Padwal; Miriam Fradette; Ann Thompson; Ross Tsuyuki; Steven A Grover; Naeem Dean; Ashfaq Shuaib
Journal:  Implement Sci       Date:  2010-04-12       Impact factor: 7.327

8.  [Secondary prophylaxis of stroke from a neurological perspective].

Authors:  G Seidel
Journal:  Herz       Date:  2013-05       Impact factor: 1.443

9.  PGF(2alpha) FP receptor contributes to brain damage following transient focal brain ischemia.

Authors:  Sofiyan Saleem; Abdullah Shafique Ahmad; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Neurotox Res       Date:  2009-02-11       Impact factor: 3.911

10.  Long-term mortality and risk of stroke after transient ischemic attack: a hospital-based cohort study.

Authors:  Christian Weimar; Jens Benemann; Roman Huber; Thomas Mieck; Stephen Kaendler; Steven Grieshammer; Zaza Katsarava; Hans-Christoph Diener
Journal:  J Neurol       Date:  2009-04-15       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.